Weight loss drugs like Ozempic and Mounjaro have become popular among celebrities. These drugs are known for their effectiveness in helping people shed pounds quickly. However, these drugs come with some surprising side effects. One of the more unusual side effects is something called "Ozempic feet. " This condition causes the skin on the tops of the feet to beco...
In a recent conversation, a high-profile figure in health policy discussed several pressing issues. This individual, now heading a major health department, has had a change of heart regarding the measles vaccine. Previously, this person had downplayed the vaccine's importance and even made inaccurate claims about its safety. However, during a recent interview, they u...
The FDA recently declared that compounding pharmacies should stop making knockoff versions of popular weight-loss and diabetes drugs, such as Zepbound and Mounjaro. However, many online pharmacies are still advertising these drugs, despite the FDA's ban. This is because some pharmacies are finding loopholes in the rules to continue their operations. The FDA's ban ta...
A growing number of people have been reporting severe eye issues after using popular weight loss injections Ozempic and Mounjaro. These drugs, known for their effectiveness in helping people shed pounds, have now been linked to conditions like nonarteritic anterior ischemic optic neuropathy or NAION. This condition happens when blood flow to the optic nerve gets bloc...
Imagine tuning in to the Super Bowl, expecting the usual fun and laughter from commercials. But one ad breaks the mold. Telehealth company Hims & Hers Health has a plan. They're using their 30-second spot to shine a light on a tough topic: America's weight problem. The ad, set to air in the third quarter, won't feature celebrities or jokes. Instead, it'll hit viewers...
This week, the United States Senate is set to question Robert F. Kennedy Jr. , who has been nominated by President Trump to lead the Department of Health and Human Services (HHS). This position holds tremendous power, governing agencies like the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). However, Kennedy's views on va...
Eli Lilly, a company based in Indianapolis, recently faced a blow when its stock prices dipped. The reason? Their weight-loss drugs, Zepbound and Mounjaro, didn't sell as well as expected. The company predicted they'd make about $13. 5 billion in the December quarter, which is less than what experts thought. Specifically, Mounjaro made $3. 5 billion, and Zepbound mad...
As we step into 2025, many Americans are eager to make some changes. A recent survey found that health, exercise, and diet are at the top of most people's lists. This isn't surprising, given that obesity has been a big issue in the U. S. for a long time. But last year, something interesting happened—the obesity rate dropped for the first time in over a decade. This i...
You've probably heard about new weight loss drugs that use hormones from your gut to help you feel full. Medications like semaglutide (Wegovy) and tirzepatide (Mounjaro) are making waves, but they come with a catch. These drugs might be helping you shed pounds, but they could also be weakening your bones and muscles. Let's dive in and see why. When you lose weight u...
These days, there's a buzz about certain weight-loss drugs like Ozempic, Wegovy, and Zepbound. A recent study by health data company Truveta found that people taking these drugs often end up seeing their doctor more. This isn't just about slimming down; it's also leading to diagnoses of other related health issues like sleep apnea, cardiovascular disease, and type 2 ...